EsoCap's novel targeted delivery platform is designed to increase mucosal contact time and drug deposition in the esophagus ESO-101, EsoCap's lead product candidate, consists of a capsule with a rolled-up,…
EsoCap AG has been selected to be featured in GoingPublic Magazine, a major German magazine for corporate finance and investment topics. "We are very pleased to be featured in GoingPublic…
EsoCap AG announced the presentation of data showing that for the first time, long-lasting topical drug therapy in the esophagus is possible with the EsoCap smart delivery technology in the…
EsoCap CEO interviewed by CCFA as part of International Women's Day. "I am very pleased to have been selected to give an interview in Caléidoscope, the journal of the CCFA…
EsoCap has announced that scientists from the University of Greifswald have published important data regarding a hot-melt extrusion-based spinning process to produce pharmaceutical fibers and yarns. This spinning process is…
EsoCap AG organized a multidisciplinary scientific advisory board meeting with eight international experts in Barrett’s esophagus (BE) in Zurich EsoCap’s technology for the topical treatment of Barrett’s esophagus was recognized…
Patients with eosinophilic esophagitis (EoE) suffer from severe symptoms including swallowing disorders, food impaction, vomiting, and heartburn EsoCap is currently conducting a randomized, placebo-controlled, double-blind Phase II trial to treat…
“We are extremely pleased that The Medicine Maker is reporting on how EsoCap’s unique and innovative topical drug delivery system offers new treatment options for diseases of the esophagus,” said…
EsoCap AG has been recognised by the special issue of Life Sciences Review Europe as a top biotech start-up. “We are extremely pleased to have been chosen for the cover…
EsoCap AG announced today that the Mexican Patent and Trademark Office has issued a patent under number 383626, based on Patent Application No. MX/a/2017/007566. The patent is directed at the…
Malzgasse 9, CH-4052 Basel
